We are live on ! Find out more
SRTS icon

Sensus Healthcare

13 hedge funds and large institutions have $5.65M invested in Sensus Healthcare in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

29% more capital invested

Capital invested by funds: $4.38M → $5.65M (+$1.26M)

18% more funds holding

Funds holding: 1113 (+2)

0.35% more ownership

Funds ownership: 8.06%8.41% (+0.35%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SRTS Hedge Fund Activity: Q3 2017 in Review

13 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q3 2017, worth a combined $5.65M — up 29% from $4.38M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SRTS positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $342K. The largest seller was B. Riley Financial, cutting an estimated $405K.

  • 13 institutional investors held Sensus Healthcare (SRTS) as of Q3 2017, up from 11 in Q2 2017.
  • Funds reported $5.65M of Sensus Healthcare stock for Q3 2017, up 29% quarter-over-quarter.
  • 5 funds opened new Sensus Healthcare positions in Q3 2017 and 3 closed out, a net change of +2 holders.
  • The largest Sensus Healthcare buyer in Q3 2017 was Millennium Management, an estimated $342K added.
  • The largest Sensus Healthcare seller in Q3 2017 was B. Riley Financial, an estimated $405K sold.

Based on aggregated 13F filings for Q3 2017.